Home / Recalls / Boothwyn Pharmacy LLC / D-0608-2025

D-0608-2025 Class II Ongoing

Recalled by Boothwyn Pharmacy LLC — Kennett Square, PA

FDA drug recall D-0608-2025 was initiated by Boothwyn Pharmacy LLC on July 9, 2025 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 186 vials.

Recall Details

Product Type: Drugs
Report Date: September 10, 2025
Initiation Date: July 9, 2025
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 186 vials

Product Description

Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy

Reason for Recall

Subpotent Drug

Distribution Pattern

U.S. Nationwide

Code Information

03202025@9 BUD 07/18/2025